Displaying drugs 1551 - 1575 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Roxadustat | 352.346 C19H16N2O5 |  | A hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease. | Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors |
| Triflupromazine | 352.417 C18H19F3N2S |  | Used mainly in the management of psychoses. Also used to control nausea and vomiting. | Phenothiazines With Aliphatic Side-Chain |
| Clidinium | 352.4467 C22H26NO3 |  | A synthetic anticholinergic used to treat peptic ulcer disease, colicky abdominal pain, diverticulitis, and IBS. | Agents producing tachycardia |
| Dinoprostone | 352.4651 C20H32O5 |  | A prostaglandin used to induce labor or abortion as well as to treat nonmetastatic gestational trophoblastic disease. | Prostaglandins |
| Epoprostenol | 352.4651 C20H32O5 |  | A vasodilator and platelet aggregation inhibitor used for the management of primary pulmonary hypertension and pulmonary hypertension in patients with heart failure. | Platelet Aggregation Inhibitors Excl. Heparin |
| Anileridine | 352.4699 C22H28N2O2 |  | An opioid analgesic used to treat moderate to severe pain. | Opioid Anesthetics |
| Encainide | 352.4699 C22H28N2O2 |  | A voltage-gated sodium channel blocker used for management of atrial or ventricular fibrillation, atrial flutter, and ventricular tachycardia, that is no longer used due to proarrhythmic adverse effects. | Antiarrhythmic agents / Antiarrhythmics, Class Ic |
| Halazepam | 352.738 C17H12ClF3N2O |  | Used to relieve anxiety, nervousness, and tension associated with anxiety disorders. | Benzodiazepines and benzodiazepine derivatives |
| Griseofulvin | 352.766 C17H17ClO6 |  | An antifungal agent used to treat a variety of superficial tinea infections and fungal infections of the fingernails and toes. | Antifungals for Systemic Use |
| Acenocoumarol | 353.3255 C19H15NO6 |  | An anticoagulant drug used in the prevention of thromboembolic diseases in infarction and transient ischemic attacks, as well as management of deep vein thrombosis and myocardial infarction. | Vitamin K Antagonists |
| Gefapixant | 353.4 C14H19N5O4S |  | A P2X3 receptor antagonist that reduces the cough reflex in patients with refractory or unexplained chronic cough. | Amides / BCRP/ABCG2 Substrates / Benzene Derivatives / Cough and Cold Preparations / MATE 1 Substrates / MATE 2 Substrates / MATE substrates / P-glycoprotein substrates / Sulfonamides / Sulfones / Sulfur Compounds |
| Methysergide | 353.458 C21H27N3O2 |  | An ergot alkaloid used for the prophylaxis of migraine and cluster headaches. | Ergot Alkaloids and Derivatives |
| Levacetylmethadol | 353.4977 C23H31NO2 |  | For the treatment and management of opiate dependence. It is sometimes used to treat severe pain in terminal patients. | Drugs Used in Opioid Dependence |
| Isopropamide | 353.5209 C23H33N2O |  | A long-acting anticholinergic drug used to relieve symptoms of spastic and painful symptoms of gastrointestinal conditions and symptoms of flu, colds, and related conditions. | Synthetic Anticholinergics, Quaternary Ammonium Compounds |
| Idoxuridine | 354.0985 C9H11IN2O5 |  | A pyrimidine analog antiviral used for the treatment of viral eye infections, including herpes simplex keratitis. | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Aceclofenac | 354.18 C16H13Cl2NO4 |  | Aceclofenac is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. | Acetic Acid Derivatives and Related Substances / Antiinflammatory Preparations, Non-Steroids for Topical Use |
| Luliconazole | 354.27 C14H9Cl2N3S2 |  | A topical antifungal agent used to treat fungal infections. | Imidazole and Triazole Derivatives |
| Valganciclovir | 354.3617 C14H22N6O5 |  | An antiviral medication used to treat cytomegalovirus (CMV) retinitis in patients diagnosed with acquired immunodeficiency syndrome (AIDS). | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Yohimbine | 354.4427 C21H26N2O3 |  | An alpha-2-adrenergic blocker and sympatholytic found in supplements used to. | Drugs Used in Erectile Dysfunction |
| Hexamidine | 354.446 C20H26N4O2 |  | An antiseptic drug used for dermatomycoses and superficial bacterial infections alone or in combination with clotrimazole. | Anti-Infective Agents, Local / Biguanides and Amidines |
| Sultopride | 354.47 C17H26N2O4S |  | Sultopride is used in Japan, Hong Kong, and Europe to treat schizophrenia. It is of the drug class atypical antipsychotics . | Benzamides and benzamide derivatives |
| Alprostadil | 354.487 C20H34O5 |  | A prostaglandin E1 agonist used for the treatment of erectile dysfunction and as an adjunct for its diagnosis. | Drugs Used in Erectile Dysfunction / Prostaglandins |
| Dinoprost | 354.487 C20H34O5 |  | A medication used to induce a second trimester abortion. | Prostaglandins |
| Olutasidenib | 354.79 C18H15ClN4O2 |  | An isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation as detected by an FDA-approved test. | Antineoplastic Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Enzyme Inhibitors / Heterocyclic Compounds, Fused-Ring / Isocitrate dehydrogenase-1 (IDH1) inhibitors / Isocitrate Dehydrogenase-1 Inhibitors / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / Potential QTc-Prolonging Agents / QTc Prolonging Agents |
| Repotrectinib | 355.373 C18H18FN5O2 |  | A tyrosine kinase inhibitor used to treat locally active or metastatic non-small cell lung cancer | BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Inhibitors / Cytochrome P-450 CYP3A5 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Kinase Inhibitor / MATE 2 Inhibitors / MATE inhibitors / OATP1B1/SLCO1B1 Inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates / ROS1 tyrosine kinase inhibitors / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors |
Displaying drugs 1551 - 1575 of 2774 in total